Abstract

Radiotherapy plays a vital role in cancer treatment, for which accurate prognosis is important for guiding sequential treatment and improving the curative effect for patients. An issue of great significance in radiotherapy is to assess tumor radiosensitivity for devising the optimal treatment strategy. Previous studies focused on gene expression in cells closely associated with radiosensitivity, but factors such as the response of a cancer patient to irradiation and the patient survival time are largely ignored. For clinical cancer treatment, a specific pre-treatment indicator taking into account cancer cell type and patient radiosensitivity is of great value but it has been missing. Here, we propose an effective indicator for radiosensitivity: radiosensitive gene group centrality (RSGGC), which characterizes the importance of the group of genes that are radiosensitive in the whole gene correlation network. We demonstrate, using both clinical patient data and experimental cancer cell lines, which RSGGC can provide a quantitative estimate of the effect of radiotherapy, with factors such as the patient survival time and the survived fraction of cancer cell lines under radiotherapy fully taken into account. Our main finding is that, for patients with a higher RSGGC score before radiotherapy, cancer treatment tends to be more effective. The RSGGC can have significant applications in clinical prognosis, serving as a key measure to classifying radiosensitive and radioresistant patients.

LanguageEnglish (US)
Pages528-536
Number of pages9
JournalJournal of Theoretical Biology
Volume462
DOIs
StatePublished - Feb 7 2019

Fingerprint

Radiotherapy
Neoplasm Genes
Centrality
radiotherapy
Cancer
Genes
Gene
neoplasms
Oncology
Radiation Tolerance
Neoplasms
genes
Cells
Survival Time
Prognosis
Cell
prognosis
Therapeutics
cell lines
Line

Keywords

  • Cancer
  • Network centrality
  • Network science
  • Radiosensitive
  • Radiotherapy

ASJC Scopus subject areas

  • Statistics and Probability
  • Modeling and Simulation
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Agricultural and Biological Sciences(all)
  • Applied Mathematics

Cite this

A network approach to quantifying radiotherapy effect on cancer : Radiosensitive gene group centrality. / Yao, Yu Xiang; Bing, Zhi Tong; Huang, Liang; Huang, Zi Gang; Lai, Ying-Cheng.

In: Journal of Theoretical Biology, Vol. 462, 07.02.2019, p. 528-536.

Research output: Contribution to journalArticle

Yao, Yu Xiang ; Bing, Zhi Tong ; Huang, Liang ; Huang, Zi Gang ; Lai, Ying-Cheng. / A network approach to quantifying radiotherapy effect on cancer : Radiosensitive gene group centrality. In: Journal of Theoretical Biology. 2019 ; Vol. 462. pp. 528-536.
@article{589e24df941442e885cacc88f82efc74,
title = "A network approach to quantifying radiotherapy effect on cancer: Radiosensitive gene group centrality",
abstract = "Radiotherapy plays a vital role in cancer treatment, for which accurate prognosis is important for guiding sequential treatment and improving the curative effect for patients. An issue of great significance in radiotherapy is to assess tumor radiosensitivity for devising the optimal treatment strategy. Previous studies focused on gene expression in cells closely associated with radiosensitivity, but factors such as the response of a cancer patient to irradiation and the patient survival time are largely ignored. For clinical cancer treatment, a specific pre-treatment indicator taking into account cancer cell type and patient radiosensitivity is of great value but it has been missing. Here, we propose an effective indicator for radiosensitivity: radiosensitive gene group centrality (RSGGC), which characterizes the importance of the group of genes that are radiosensitive in the whole gene correlation network. We demonstrate, using both clinical patient data and experimental cancer cell lines, which RSGGC can provide a quantitative estimate of the effect of radiotherapy, with factors such as the patient survival time and the survived fraction of cancer cell lines under radiotherapy fully taken into account. Our main finding is that, for patients with a higher RSGGC score before radiotherapy, cancer treatment tends to be more effective. The RSGGC can have significant applications in clinical prognosis, serving as a key measure to classifying radiosensitive and radioresistant patients.",
keywords = "Cancer, Network centrality, Network science, Radiosensitive, Radiotherapy",
author = "Yao, {Yu Xiang} and Bing, {Zhi Tong} and Liang Huang and Huang, {Zi Gang} and Ying-Cheng Lai",
year = "2019",
month = "2",
day = "7",
doi = "10.1016/j.jtbi.2018.12.001",
language = "English (US)",
volume = "462",
pages = "528--536",
journal = "Journal of Theoretical Biology",
issn = "0022-5193",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - A network approach to quantifying radiotherapy effect on cancer

T2 - Journal of Theoretical Biology

AU - Yao, Yu Xiang

AU - Bing, Zhi Tong

AU - Huang, Liang

AU - Huang, Zi Gang

AU - Lai, Ying-Cheng

PY - 2019/2/7

Y1 - 2019/2/7

N2 - Radiotherapy plays a vital role in cancer treatment, for which accurate prognosis is important for guiding sequential treatment and improving the curative effect for patients. An issue of great significance in radiotherapy is to assess tumor radiosensitivity for devising the optimal treatment strategy. Previous studies focused on gene expression in cells closely associated with radiosensitivity, but factors such as the response of a cancer patient to irradiation and the patient survival time are largely ignored. For clinical cancer treatment, a specific pre-treatment indicator taking into account cancer cell type and patient radiosensitivity is of great value but it has been missing. Here, we propose an effective indicator for radiosensitivity: radiosensitive gene group centrality (RSGGC), which characterizes the importance of the group of genes that are radiosensitive in the whole gene correlation network. We demonstrate, using both clinical patient data and experimental cancer cell lines, which RSGGC can provide a quantitative estimate of the effect of radiotherapy, with factors such as the patient survival time and the survived fraction of cancer cell lines under radiotherapy fully taken into account. Our main finding is that, for patients with a higher RSGGC score before radiotherapy, cancer treatment tends to be more effective. The RSGGC can have significant applications in clinical prognosis, serving as a key measure to classifying radiosensitive and radioresistant patients.

AB - Radiotherapy plays a vital role in cancer treatment, for which accurate prognosis is important for guiding sequential treatment and improving the curative effect for patients. An issue of great significance in radiotherapy is to assess tumor radiosensitivity for devising the optimal treatment strategy. Previous studies focused on gene expression in cells closely associated with radiosensitivity, but factors such as the response of a cancer patient to irradiation and the patient survival time are largely ignored. For clinical cancer treatment, a specific pre-treatment indicator taking into account cancer cell type and patient radiosensitivity is of great value but it has been missing. Here, we propose an effective indicator for radiosensitivity: radiosensitive gene group centrality (RSGGC), which characterizes the importance of the group of genes that are radiosensitive in the whole gene correlation network. We demonstrate, using both clinical patient data and experimental cancer cell lines, which RSGGC can provide a quantitative estimate of the effect of radiotherapy, with factors such as the patient survival time and the survived fraction of cancer cell lines under radiotherapy fully taken into account. Our main finding is that, for patients with a higher RSGGC score before radiotherapy, cancer treatment tends to be more effective. The RSGGC can have significant applications in clinical prognosis, serving as a key measure to classifying radiosensitive and radioresistant patients.

KW - Cancer

KW - Network centrality

KW - Network science

KW - Radiosensitive

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85057722780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057722780&partnerID=8YFLogxK

U2 - 10.1016/j.jtbi.2018.12.001

DO - 10.1016/j.jtbi.2018.12.001

M3 - Article

VL - 462

SP - 528

EP - 536

JO - Journal of Theoretical Biology

JF - Journal of Theoretical Biology

SN - 0022-5193

ER -